The acquisition of Pronova BioPharma in January 2013, of Equateq, today BASF Pharma (Callanish), in May 2012 and of Cognis in December 2010 has made BASF a global market leader for omega-3 fatty acids. The newly created portfolio now covers the full range from low to medium to high-concentrate omega-3 fatty acids – for pharmaceuticals, dietary supplements and clinical nutrition. Additionally BASF's offer includes high quality Omega-3 powders for food and infant nutrition applications. Besides its broad portfolio, BASF offers global customer reach, solid know-how and scientific expertise in the production of omega-3 fatty acids.
The Omega-3 Verbund has four production facilities in Norway, Denmark and Scotland and the headquarters in Lilleaker (Oslo), Norway.
Company Category
- Refiner/Concentrator
- Contract Manufacturer
- Finished Product Company
- Other
Raw Material Source
- Fish
Omega-3 Chemical Form
- Triglyceride
- Ethyl Ester
Product Form
- Capsules
- Oil (Concentrate)
- Powder
- Other
Finished Product Category
- Clinical Nutrition/Medical Foods
- Dietary Supplement
- Pharmaceutical